Vimarsana
Biggest News Aggregation in the World

After Mild News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from After Mild. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In After Mild Today - Breaking & Trending Today

Mild COVID-19 Infection Linked to Later Type 2 Diabetes - Vimarsana News

Mild COVID-19 Infection Linked to Later Type 2 Diabetes

Results point to the need to monitor blood glucose following SARS-CoV-2 infection.

Long COVID and the Fifth Wave - The Hidden Pandemic - Vimarsana News

Long COVID and the Fifth Wave - The Hidden Pandemic

This article, using current knowledge, focuses on long COVID. It looks at what is Long COVID and starts highlighting possible impacts.

Links 4/11/2021 | naked capitalism - Vimarsana News

Links 4/11/2021 | naked capitalism

“ Only you are responsible for your own health.” That is the stupid American credo, weaponized. It’s called “public health” for a reason. Yes, the medical system is full of corruption and gaslighting and fraud, and yes, each of us is well advised to do our due diligence when it comes to the health of ourselves and those we care about. But only institutions, acting through lots of workers, can detect and deal with broad threats to health and welfare, and it’s so dopey that in so much of the world, that kind of pro-social activity gets sh!tcanned for profit or politics. And now the...

One in ten have long-term effects 8 months following mild COVID-19 - Vimarsana News

One in ten have long-term effects 8 months following mild COVID-19

Credit: Ludvig Kostyal Eight months after mild COVID-19, one in ten people still has at least one moderate to severe symptom that is perceived as having a negative impact on their work, social or home life. The most common long-term symptoms are a loss of smell and taste and fatigue. This is according to a study published in the journal JAMA, conducted by researchers at Danderyd Hospital and Karolinska Institutet in Sweden. Since spring 2020, researchers at Danderyd Hospital and Karolinska Institutet have conducted the so-called COMMUNITY study, with the main purpose of examining immunity af...

Salivary IgG to SARS-CoV-2 after mild COVID-19 - Vimarsana News

Salivary IgG to SARS-CoV-2 after mild COVID-19

Salivary IgG to SARS-CoV-2 after mild COVID-19 A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have antibodies for the disease up to nine months after acquiring the disease, even if they displayed only mild symptoms. Concerns of COVID reinfection Symptoms of SARS-CoV-2, the underlying agent for coronavirus disease 2019 (COVID-19), vary massively amongst populations of different age groups and health conditions. Most notably, people over the age of 60, and those with underlying health co...